Compare CQP & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CQP | ALC |
|---|---|---|
| Founded | 2003 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Ophthalmic Goods |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 35.9B |
| IPO Year | 2006 | 2002 |
| Metric | CQP | ALC |
|---|---|---|
| Price | $62.87 | $78.01 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $60.43 | ★ $89.38 |
| AVG Volume (30 Days) | 123.4K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.23% | 0.24% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $10,758,000,000.00 | N/A |
| Revenue This Year | $5.71 | $8.10 |
| Revenue Next Year | $1.88 | $6.31 |
| P/E Ratio | $906.00 | ★ $38.31 |
| Revenue Growth | ★ 23.60 | N/A |
| 52 Week Low | $49.53 | $71.55 |
| 52 Week High | $70.64 | $99.20 |
| Indicator | CQP | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 54.63 |
| Support Level | $62.10 | $77.59 |
| Resistance Level | $70.64 | $81.84 |
| Average True Range (ATR) | 2.62 | 1.50 |
| MACD | -0.65 | 0.57 |
| Stochastic Oscillator | 5.36 | 81.64 |
Cheniere Energy Partners is a liquified natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.